Your Article Summary
See Latest ArticlesA Multiple-Center, Randomized, Double-Blind, Placebo-Controlled Study of Oral Aripiprazole for Treatment of Adolescents With Schizophrenia
American Journal of Psychiatry, 11/20/08
Findling RL et al. - Both 10- and 30-mg/day doses of aripiprazole were superior to placebo in the acute treatment of adolescents with schizophrenia. Aripiprazole was generally well tolerated.
Related Articles
Auditory gating deficit to human voices in schizophrenia: A MEG study
Schizophrenia Research, 10/01/09
Relevance Score: 93%
Age at onset and cognition in schizophrenia: meta-analysis
British Journal of Psychiatry, 10/06/09
Relevance Score: 92%
Beyond symptom dimensions: Schizophrenia risk factors for patient groups derived by latent class analysis
Schizophrenia Research, 10/30/09
Relevance Score: 91%
Functional Magnetic Resonance Imaging of Inner Speech in Schizophrenia
Biological Psychiatry, 10/26/09
Relevance Score: 91%
Sensory Processing in Schizophrenia: Neither Simple nor Intact
Schizophrenia Bulletin, 10/19/09
Relevance Score: 91%
Today in Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Medical waiting periods: imminence, emotions and coping
Women's Health, 12/19/09
The Role of Public Health in Addressing Racial and Ethnic Disparities in Mental Health and Mental Illness
Preventing Chronic Disease, 12/18/09
Evolving Definitions of Mental Illness and Wellness
Preventing Chronic Disease, 12/18/09